Document is current
Any future updates will be listed below
-
Authors
Myhre, Anders Eivind https://orcid.org/0009-0005-8459-4209
Meyer-Myklestad, Malin Holm https://orcid.org/0000-0003-3162-5196
Gullaksen, Hanne Hestdal https://orcid.org/0009-0007-1177-4262
Søgaard, Ole S. https://orcid.org/0000-0001-9107-2023
Tolstrup, Martin
Salgado, Maria
Martinez-Picado, Javier https://orcid.org/0000-0002-4916-2129
Holberg-Petersen, Mona
Juhl, Anna Karina
Schleimann, Mariane H.
Gunst, Jesper D. https://orcid.org/0000-0002-3787-0259
Thomsen, Astrid
Fisher, Katie https://orcid.org/0000-0002-8732-706X
Bhamra, Jagjit Singh https://orcid.org/0000-0002-8423-8440
Kran, Anne-Marte Bakken
Halvorsen, Bente
Dyrhol-Riise, Anne Ma
Reikvam, Dag Henrik
Aukrust, Pål
Gedde-Dahl, Tobias
,
Aass, Hans Christian D.
Aukrust, Pål
Bakken-Kran, Anne Marte
Bhamra, Jagiit S.
Bjørås, Magnar
Dahl, Tuva B.
Dyrhol-Riise, Anne Ma
Gedde-Dahl, Tobias
Guldsten, Hanne
Gullaksen, Hanne H.
Halvorsen, Bente
Holberg-Petersen, Mona
Høivik, Marte L.
Jahnsen, Frode L.
Kaarbø, Mari
Lind, Andreas
Løvgården, Gunilla
Medhus, Asle W.
Meyer-Myklestad, Malin H.
Müller, Fredrik
Myhre, Anders E.
Nur, Sarah
Rashidi, Azita
Reikvam, Dag Henrik
Trøseid, Marius
Moksnes, Magnus
Fisher, Katie
Gunst, Jesper D.
Juhl, Anna Karina
Schleimann, Mariane H.
Søgaard, Ole
Thomsen, Astrid
Tolstrup, Martin
Campos, Gerard
Rivas, Gema Fernández
García Guerrero, Maria del Carmen
Navarro, Irene González
Soler, Victoria González
Hernández, Águeda
Martinez-Picado, Javier
Salgado, Maria
Nowak, Piotr
Sönnerborg, Anders
Dahl, Tuva Børresdatter https://orcid.org/0000-0001-7818-9411
Kaarbø, Mari
Trøseid, Marius https://orcid.org/0000-0001-7775-3404
- License Information
-
More Information
Article History
Received: 23 June 2025
Accepted: 19 February 2026
First Online: 13 April 2026
Competing interests
: A.E.M. has received consultancy fees and research funding from Medac (treosulfan), speaker honoraria from Novartis (ruxolitinib) and consultancy and speaking fees from Takeda (vedolizumab); none of which were related to this study. M.H.M.-M. has received consultancy and speaker fees from GSK and ViiV Healthcare; none of which were related to this study. The other authors declare no competing interests.
